234 BATH ROAD, SLOUGH, BERKSHIRE, X0
Annual Report to Security Holders
Indivior Pharmaceuticals Issues $500 Million Convertible Senior Notes
Other Events
Announces Proposed Convertible Senior Notes Offering
Reports Fourth Quarter and Full-Year 2025 Financial Results
Executive Compensation Clawback Policy
Investor Presentation
Announces Inclusion in the S&P SmallCap 600® Index
FY 2024
Q3
Q2
Q1
Annual and Transition Report of Foreign Private Issuers
Notice of Suspension of Duty to File Reports
Registration Statement for Securities to be Offered to Employees
Certificate
Amended Direct Registration System
Additional Proxy Materials
Definitive Proxy Statement
Definitive Additional Information Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
S-8 POS